Table 3.
Cell populationa | NT (%) | Acthar (%) | Placebo gel (%) |
---|---|---|---|
CD45+ total | 57.5 ± 3.9 | 39.4 ± 15.4 | 54.7 ± 11.9 |
CD45+ CD3+ | 78.6 ± 4.3 | 86.9 ± 2.2 | 85.2 ± 2.6 |
CD45+ CD3+ CD4+ | 55.6 ± 6.1 | 40.3 ± 6.8 | 59.4 ± 0.9 |
CD45+ CD19+ | 0.146 ± 0.1 | 0.1 ± 0.1 | 0.3 ± 0.2 |
R1 | 18.0 ± 2.9 | 50.6 ± 18.7 | 17.6 ± 1.7 |
R2 | 32.5 ± 1.2 | 19.3 ± 9.6 | 22.4 ± 3.1 |
R1/R2 | 0.55 | 2.62 | 0.79 |
Cell populations were gated on 7-AAD negative (viable) cells.
NT no treatment.
Spinal cord cells from to 2–3 mice/group were pooled for a total of three pooled groups for each treatment.
Data represent the mean ± SEM.